EBC - ON DEMAND
Stentys in bifurcation lesions: 12 months Follow-up of a prospec/ve study
European Bifurcation Club 2014 – EBC 2014 – Bordeaux, France
At last randomized trials with dedicated bifurcation stents!
Stentys in bifurcation lesions: 12 months Follow-up of a prospec/ve study
Author: Stylianos A. Pyxaras, MD, Contilia Heart and Vascular Centre Elisabeth-Krankenhaus Essen, Germany
AIM
To evaluate the long-term safety and efficacy of the STENTYS self-apposing paclitaxel-eluting stent (STENTYS-PES) in bifurcation lesions in routine clinical practice
CONCLUSION
- In a prospective, multicentric experience, STENTYS-PES has satisfactory long-term outcome
- Stentys-PES has successfully been used as an alternative to provisional strategy with balloon expandable stents, allowing additional SB access whenever required
- Device and procedural success achieved high rates in an all- comer, prospectively enrolled population
- No significant differences regarding MACE at 6- and 12- months were observed in patients treated with or without FKB